CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution

Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo

Cancer Research and Treatment. 2013;45(3):178-185. Published online 2013 September 30 DOI: https://doi.org/10.4143/crt.2013.45.3.178

How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution

Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo

Cancer Research and Treatment. 2013;45(3):178-185

Link1

Link2

The use of gefitinib in the management of non small cell lung cancer: a single institution experience

A. Srivastava, A.R.A. Razak, J. Gardiner, G. Mazdai, A. Hughes

Lung Cancer. 2008;60:S25

Link1 Link2

Outcome of pneumonectomy for primary non-small cell lung cancer — A ten-year experience

Lung Cancer. 1995;13(2):212

Link1 Link2

139P ERLOTINIB VERSUS GEFITINIB TREATMENT FOR NON-SMALL CELL LUNG CANCER (NSCLC): A SINGLE INSTITUTION EXPERIENCE IN KOREA

S.Y. Lee, J.H. Kim, K.H. In, H.K. Kim, S.E. Kim, Y.K. Kim, H.S. Yong, K.H. Kang, D.Y. Kang, D.S. Yang

Lung Cancer. 2009;64:S58

Link1 Link2

19 A single centre experience of gefitinib in patients with EGFR mutation positive non small cell lung cancer

H.S. Walter, D.A. Fennell, S.I. Ahmed

Lung Cancer. 2013;79:S7

Link1 Link2

Gefitinib In Pretreated Patients with Advanced Non- Small Cell Lung Cancer - Single Institution Experience

Irina Lazarev, Julia Dudnik, Shmuel Ariad, Wilmosh Mermershtain

Indian Journal of Medical and Paediatric Oncology. 2006;27(02):10-13

Link1

82P COMBINED MODALITY THERAPY OF ADVANCED NON-SMALL-CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCE

B. Resuli

Lung Cancer. 2013;80:S36-S37

Link1 Link2

A single institution experience on concurrent chemoradiotherapy (CCT) in non-small cell lung cancer (NSCLC)

Mahbuba Choudhury, Dakshinamoorthy MuthuKumar

Lung Cancer. 2021;156:S55

Link1 Link2

38 Patterns of relapse and detection method in patients with resected non-small cell lung cancer (NSCLC) – a single institution experience

A. Pender, J. Coward, R. Gunapala, J. Bhosle, M. O'Brien, S. Popat

Lung Cancer. 2014;83:S15

Link1 Link2

Erlotinib in non-small lung cancer: a single institution experience

S.A.J. Rizvi, H. Eldeeb

Lung Cancer. 2018;115:S32

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.